Founded in Vršac on 1st June 1960, Hemofarm A.D. is currently the leading generic pharmaceutical company in Serbia and in the region.
Manufacturing high-quality, effective, safe, and affordable pharmaceutical products is the core activity of the company. Since 2006, Hemofarm has been a part of the German STADA Group, one of the largest generic pharmaceutical companies in the world.
In addition to its headquarters in Vršac, Hemofarm has registered representative offices in Belgrade, Niš, Novi Sad, and Kragujevac. Šabac is the seat of the subsidiary company that became a part of Hemofarm A.D. through an acquisition in January 2015.
Apart from Serbia, Hemofarm also has subsidiaries in the region – in Macedonia, Bosnia and Herzegovina, Montenegro, and Romania. Apart from the subsidiary in Romania, there is also a Hemofarm’s European laboratory in Timisoara.
Business in Serbia
Hemofarm manufactures about 5.5 billion tablets and capsules annually.
It operates on three continents and it has a team of over 3,000 employees.
In addition to being present in 36 markets around the World, Hemofarm is among the largest pharmaceutical manufacturers in this region.
The company is a leader in the pharmaceutical market of Serbia. Taking up over 70% of the total exports of pharmaceutical products, the Vršac-based company is at the same time the largest Serbian exporter of drugs.
„Serbia offers an ideal base for business activities throughout Eastern Europe. A strong argument for investing in Serbia is also the access to highly qualified employees, and thus the ability to produce and develop products of the highest quality economically.”.
Dr. Ronald Seeliger, CEO, Stada Group/Hemofarm